Complementary roles of GPU-accelerated Monte Carlo and ArcCHECK in TomoTherapy quality assurance
Panxia Wu1,2, Wenheng Zheng1, Longfei Xu1
1Department of Radiation Oncology, Jiangxi Cancer Hospital (The Second Affiliated Hospital of Nanchang Medical College), Nanchang, 330029, Jiangxi, China.
Abstract:
The complex dose delivery mechanisms of TomoTherapy (TOMO) demand rigorous patient-specific quality assurance (PSQA). This study systematically evaluates the relationship between ArcCHECK measurements and GPU-accelerated Monte Carlo (GPU-MC) calculations for nasopharyngeal carcinoma (NPC) TOMO plans across multiple gamma criteria, aiming to delineate their respective strengths and inform an optimized verification strategy. A retrospective analysis was conducted on 317 TOMO plans for NPC, each optimized using the Accuray Precision Treatment Planning System. Patient-specific dose verification was performed using ArcCHECK measurements and independent MC calculations implemented through PlanQA. Gamma passing rates (GPRs) were evaluated under nine different conditions, including both same-criterion and cross-criterion comparisons. To assess differences, agreement, and correlations between methods, statistical analyses were conducted using the Wilcoxon signed-rank test, Bland-Altman analysis, and Spearman correlation. Under identical Gamma criteria, there was no statistically significant difference in GPR between ArcCHECK and MC. However, cross-criterion comparisons revealed marked discrepancies, highlighting the criterion-dependent nature of GPR outcomes. Lenient standards typically exhibit good consistency and relatively minor deviations. Furthermore, the correlations among all combinations of these standards can be considered negligible. The comparable performance of GPU-MC and ArcCHECK under conventional criteria (3%/3 mm, 3%/2 mm) validates ArcCHECK's established role in verifying delivery fidelity. Crucially, under the stringent 2%/2 mm criterion where ArcCHECK passing rates decline, MC provides critical diagnostic power to differentiate between discrepancies originating from the dose calculation algorithm and those arising from the physical delivery process. For TOMO PSQA, GPU-MC and ArcCHECK are complementary. An integrated approach leveraging both methods is therefore recommended.
Related Concept Videos
Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Quality Assurance
Imaging Studies III: Computed Tomography
Radiological Investigation I: X-ray and CT

